Identi cation and validation of an m6a-related lncrna signature to predict progression-free survival in colorectal cancer

HIGHLIGHTS

  • who: Colorectal Cancer and colleagues from the Department of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China, Branch have published the Article: Identi cation and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer, in the Journal: (JOURNAL)
  • what: Considering that large studies have explored the value of the m6A-related lncRNA signature for predicting overall survival (OS) in CRC , the authors focused on PFS. The authors developed and validated an m6A-Lnc signature to predict PFS in CRC patients. Dependent ROC analysis was conducted to compare . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?